
Sign up to save your podcasts
Or


Ingmar Gorman, Ph.D. clinical psychologist and principal investigator in MAPS' research into MDMA-assisted psychotherapy, is our guest this week. Ingmar shares with us his journey into the world of psychedelic therapy, and what he hopes the research at MAPS can achieve. We also discuss the rise of microdosing, and why Ingmar believes we should be cautious about its benefits.
For show links: https://thethirdwave.co/podcast/episode-47-ingmar-gorman/
Sign up to our microdosing course! https://thethirdwave.co/microdosing-course/
By Third Wave4.7
306306 ratings
Ingmar Gorman, Ph.D. clinical psychologist and principal investigator in MAPS' research into MDMA-assisted psychotherapy, is our guest this week. Ingmar shares with us his journey into the world of psychedelic therapy, and what he hopes the research at MAPS can achieve. We also discuss the rise of microdosing, and why Ingmar believes we should be cautious about its benefits.
For show links: https://thethirdwave.co/podcast/episode-47-ingmar-gorman/
Sign up to our microdosing course! https://thethirdwave.co/microdosing-course/

2,553 Listeners

10,573 Listeners

3,997 Listeners

11,904 Listeners

1,884 Listeners

2,631 Listeners

1,291 Listeners

12,730 Listeners

1,926 Listeners

559 Listeners

1,665 Listeners

1,046 Listeners

184 Listeners

625 Listeners

221 Listeners